Pacira BioSciences Long Term Debt Current 2011-2026 | PCRX

Annual Long Term Debt Current Pacira BioSciences

2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
8.89 M	8.8 M	9.12 M	7.89 M	7.42 M	4.94 M	-	-	-	119 M	120 M	120 M	-	7.04 M

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
120 M	4.94 M	41.3 M

Long Term Debt Current of other stocks in the Drug manufacturers industry

Issuer	Long Term Debt Current	Price	% 24h	Market Cap	Country
Cumberland Pharmaceuticals CPIX	468 K	$ 5.87	6.53 %	$ 87.2 M	USA
Endo International plc ENDP	956 K	-	-	$ 28.9 M	Irlanda
Evoke Pharma EVOK	59.5 K	-	-	$ 36.6 M	USA
HEXO Corp. HEXO	914 K	-	2.45 %	$ 38.1 M	Canada
Calliditas Therapeutics AB (publ) CALT	12.5 M	-	-0.1 %	$ 2.03 B	Schweden
AcelRx Pharmaceuticals ACRX	100 K	-	7.5 %	$ 6.35 M	USA
DURECT Corporation DRRX	1.08 M	-	-	$ 50.1 M	USA
Adamis Pharmaceuticals Corporation ADMP	343 K	-	0.86 %	$ 117 M	USA
Aerie Pharmaceuticals AERI	4.36 M	-	-	$ 754 M	USA
Agile Therapeutics AGRX	366 K	-	10.11 %	$ 58.2 M	USA
Alimera Sciences ALIM	634 K	-	-	$ 142 M	USA
Cronos Group CRON	337 K	$ 2.74	0.37 %	$ 1.05 B	Canada
Harrow Health HROW	887 K	$ 33.0	0.12 %	$ 1.21 B	USA
Athenex ATNX	2.09 M	-	-23.39 %	$ 1.76 M	USA
Avadel Pharmaceuticals plc AVDL	582 K	-	-	$ 2.06 B	France
Catalent CTLT	13 M	-	-	$ 11.5 B	USA
Organogenesis Holdings ORGO	4.95 M	$ 2.66	-	$ 337 M	USA
Eagle Pharmaceuticals EGRX	1.53 M	-	-39.89 %	$ 27.7 M	USA
Bausch Health Companies BHC	61 M	$ 5.47	0.37 %	$ 2 B	Canada
Canopy Growth Corporation CGC	7.46 M	$ 1.04	-2.8 %	$ 112 M	Canada
Tilray TLRY	2.47 M	$ 5.29	-3.11 %	$ 3.27 B	Canada
Solid Biosciences SLDB	2.1 M	$ 6.62	1.85 %	$ 579 M	USA
Aurora Cannabis ACB	5.38 M	$ 3.46	-2.81 %	$ 190 M	Canada
Sonoma Pharmaceuticals SNOA	58 K	$ 1.1	3.77 %	$ 1.37 M	USA
Jupiter Wellness JUPW	23.5 K	-	-	$ 33.6 M	USA
Lannett Company LCI	2.06 M	-	1.15 %	$ 7.11 M	USA
OrganiGram Holdings OGI	1.03 M	$ 1.12	-0.88 %	$ 107 M	Canada
Evolus EOLS	2.53 M	$ 6.09	-5.58 %	$ 393 M	USA
Sundial Growers SNDL	35.5 M	$ 1.45	-1.36 %	$ 3.37 M	Canada
Emergent BioSolutions EBS	2.4 M	$ 8.45	0.96 %	$ 433 M	USA
Veru VERU	759 K	$ 2.35	5.86 %	$ 34.4 M	USA
Neoleukin Therapeutics NLTX	3.05 M	-	-	$ 193 M	Canada
cbdMD YCBD	778 K	$ 0.76	-2.32 %	$ 3.06 M	USA
Assertio Holdings ASRT	240 K	$ 23.44	0.3 %	$ 150 M	USA
ProPhase Labs PRPH	301 K	-	-	$ 5.07 M	USA
Radius Health RDUS	613 K	-	-	$ 1.42 B	USA
PetIQ PETQ	7.61 M	-	1.64 %	$ 400 M	USA
Recro Pharma REPH	1.1 M	-	-4.76 %	$ 65.3 M	USA
OptiNose OPTN	911 K	-	-	$ 1.08 B	USA
SCYNEXIS SCYX	483 K	$ 0.73	3.0 %	$ 36.5 M	USA
PLx Pharma PLXP	622 K	-	-27.8 %	$ 2.56 M	USA
Viatris VTRS	109 M	$ 16.65	1.15 %	$ 19.4 B	USA
Zomedica Corp. ZOM	717 K	-	-0.21 %	$ 98 M	USA
Zynerba Pharmaceuticals ZYNE	215 K	-	-	$ 55.5 M	USA
Rockwell Medical RMTI	1.16 M	$ 0.79	-2.06 %	$ 28.4 M	USA
Tricida TCDA	2.74 M	-	-	$ 3.25 M	USA
China Pharma Holdings CPHI	71.6 K	$ 0.76	-0.29 %	$ 3.26 M	China
TherapeuticsMD TXMD	975 K	$ 2.12	0.47 %	$ 24.5 M	USA